Bryan J. Barratt
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
Genetic Associations and Epidemiology, Lipoproteins and Cardiovascular Health, Diabetes and associated disorders, Pancreatic function and diabetes, Genetic Mapping and Diversity in Plants and Animals
Most-Cited Works
- → Haplotype tagging for the identification of common disease genes(2001)1,176 cited
- → Genome-wide association studies: theoretical and practical concerns(2005)1,155 cited
- → Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial(2010)795 cited
- → Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus(2004)494 cited
- → Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis(2007)365 cited
- → Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction(2012)288 cited
- → Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins(2014)273 cited
- → Case/pseudocontrol analysis in genetic association studies: A unified framework for detection of genotype and haplotype associations, gene‐gene and gene‐environment interactions, and parent‐of‐origin effects(2004)228 cited
- → Remapping the Insulin Gene/IDDM2 Locus in Type 1 Diabetes(2004)223 cited
- → Evaluation of Single Nucleotide Polymorphism Typing with Invader on PCR Amplicons and Its Automation(2000)215 cited